Clinical trials for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement
24 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT06326008Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical TrialBeijing GoBroad Hospital
- RECRUITINGPhase 2NCT06859424A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationCenter for International Blood and Marrow Transplant Research
- RECRUITINGPHASE2, PHASE3NCT06860269A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic LeukemiaAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT06895538Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic MalignancyPeking University First Hospital
- RECRUITINGN/ANCT06960993Mosaic Trial for Stem Cell Transplant RecipientsNorthwestern University
- RECRUITINGPhase 2NCT06816134Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute LeukemiaThe First Affiliated Hospital of Soochow University · PI: Sheng-Li Xue, M.D.
- RECRUITINGPhase 2NCT06608732Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.Institute of Hematology & Blood Diseases Hospital, China
- ACTIVE NOT RECRUITINGN/ANCT05968963Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell TransplantationUniversity of Miami · PI: Frank J. Penedo, PhD
- RECRUITINGN/ANCT05190653Early Integration of Palliative and Supportive Care in Cellular TherapyAlberta Health Services, Calgary · PI: Reanne Booker, PhD(c)
- ACTIVE NOT RECRUITINGPhase 2NCT04904588HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideCenter for International Blood and Marrow Transplant Research · PI: Steven Devine, MD
- RECRUITINGPhase 1NCT03533816Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant CyclophosphamideUniversity of Kansas Medical Center · PI: Joseph McGuirk, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT04232241Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute LeukemiaUniversitätsklinikum Hamburg-Eppendorf · PI: Nicolaus Kröger, Prof. Dr.
- RECRUITINGNCT04014374Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With MogamulizumabKyowa Kirin, Inc.
- ACTIVE NOT RECRUITINGPhase 3NCT03057054Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell TransplantChildren's Oncology Group · PI: Michael L Nieder
- RECRUITINGPhase 1NCT03326921HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantFred Hutchinson Cancer Center · PI: Elizabeth Krakow
- RECRUITINGEarly Phase 1NCT06643221Exercise as an Immune Adjuvant for Allogeneic Cell TherapiesUniversity of Arizona
- RECRUITINGPhase 1NCT02508038Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsUniversity of Wisconsin, Madison · PI: Christian Capitini, MD
- ACTIVE NOT RECRUITINGPhase 1NCT02050347Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)Baylor College of Medicine · PI: Carlos A Ramos, MD
- RECRUITINGPHASE2, PHASE3NCT01949129Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaSt. Anna Kinderkrebsforschung · PI: Christina Peters, Prof. MD PhD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT01744223Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell TransplantBellicum Pharmaceuticals · PI: Bellicum Pharmaceuticals
- RECRUITINGNCT01608152Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant SurvivorsM.D. Anderson Cancer Center · PI: Susan K Peterson
- ACTIVE NOT RECRUITINGPhase 1NCT01044069Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19Memorial Sloan Kettering Cancer Center · PI: Jae Park, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT00544466Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological MalignanciesCity of Hope Medical Center · PI: Joseph Rosenthal, MD
- ACTIVE NOT RECRUITINGPhase 2NCT00534430Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic CancerCity of Hope Medical Center · PI: Anthony S. Stein, MD